Calcitriol PCD Pharma Franchise Company

Cafoli Lifecare offers a Calcitriol range of 11 formulations across softgels and tablets, manufactured in WHO-GMP certified facilities. Distributors serving orthopaedic, gynaecology, nephrology and general practice can secure district-wise monopoly franchise rights with full promotional support.

What is Calcitriol?

Calcitriol is the biologically active form of vitamin D (1,25-dihydroxyvitamin D3). It promotes intestinal absorption of calcium and phosphate and regulates bone mineralisation, and because it needs no further activation it is used where the body cannot convert ordinary vitamin D, such as in kidney disease. Reference: PubChem - Calcitriol.

Available Forms

The Cafoli Calcitriol portfolio includes Softgels and Tablets, commonly combined with calcium, vitamin K2-7, zinc and other minerals for bone-health formulations. Contact us for current pack presentations and combinations.

Therapeutic Applications

Calcitriol is prescribed for osteoporosis, calcium and vitamin D deficiency, hypocalcaemia, renal osteodystrophy in chronic kidney disease, and bone health in pregnancy and the elderly. Prescribers include orthopaedic surgeons, gynaecologists, nephrologists, endocrinologists and general physicians.

Why Calcitriol is a High-Potential Molecule for Distributors

Calcium and active vitamin D combinations are among the highest-volume chronic supplements in India, driven by widespread deficiency, osteoporosis and antenatal supplementation. Calcitriol-calcium softgels are prescribed for months at a time by ortho, gynae and physician prescribers alike, giving distributors a broad-base, high-repeat product that anchors a bone-health range.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers monopoly franchise rights, WHO-GMP certified manufacturing, DCGI-approved formulations, a network of 1000+ franchise partners across India, and free promotional inputs.

References

1. PubChem: Calcitriol
2. MedlinePlus: Calcitriol
3. PubMed: calcitriol in bone and renal disease